Steven E. Rodgers Acquires 30,000 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAHGet Rating) Director Steven E. Rodgers purchased 30,000 shares of the stock in a transaction that occurred on Tuesday, May 17th. The stock was acquired at an average cost of $2.84 per share, with a total value of $85,200.00. Following the completion of the acquisition, the director now directly owns 30,000 shares of the company’s stock, valued at $85,200. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of NASDAQ AVAH traded up $0.21 during mid-day trading on Thursday, hitting $2.93. 646,643 shares of the company were exchanged, compared to its average volume of 540,272. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 1.84. The stock has a 50 day simple moving average of $3.68 and a 200-day simple moving average of $5.45. Aveanna Healthcare Holdings Inc. has a 1-year low of $2.09 and a 1-year high of $13.00. The firm has a market cap of $541.26 million and a price-to-earnings ratio of -5.65.

Aveanna Healthcare (NASDAQ:AVAHGet Rating) last issued its quarterly earnings results on Monday, March 28th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.11 by ($0.01). Aveanna Healthcare had a positive return on equity of 8.90% and a negative net margin of 5.70%. The company had revenue of $414.07 million for the quarter, compared to analyst estimates of $420.19 million. Analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.36 earnings per share for the current fiscal year.

AVAH has been the subject of a number of research analyst reports. Zacks Investment Research raised Aveanna Healthcare from a “sell” rating to a “hold” rating in a report on Tuesday, April 19th. Truist Financial lowered their price target on Aveanna Healthcare from $10.00 to $5.00 and set a “buy” rating for the company in a report on Wednesday, March 30th. Royal Bank of Canada lowered their price target on Aveanna Healthcare from $16.00 to $9.00 and set an “outperform” rating for the company in a report on Thursday, March 31st. Raymond James lowered their price target on Aveanna Healthcare from $12.00 to $8.00 and set a “strong-buy” rating for the company in a report on Thursday, March 31st. Finally, Deutsche Bank Aktiengesellschaft decreased their price objective on Aveanna Healthcare from $12.50 to $6.00 and set a “buy” rating for the company in a report on Wednesday, March 30th. Three equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $8.90.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Nut Tree Capital Management LP raised its position in Aveanna Healthcare by 40.2% in the fourth quarter. Nut Tree Capital Management LP now owns 5,435,479 shares of the company’s stock worth $40,223,000 after acquiring an additional 1,557,591 shares in the last quarter. Principal Financial Group Inc. raised its position in Aveanna Healthcare by 82.2% in the fourth quarter. Principal Financial Group Inc. now owns 2,325,176 shares of the company’s stock worth $17,207,000 after acquiring an additional 1,048,779 shares in the last quarter. Vaughan Nelson Investment Management L.P. raised its position in Aveanna Healthcare by 23.5% in the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 5,354,228 shares of the company’s stock worth $39,621,000 after acquiring an additional 1,018,895 shares in the last quarter. Westwood Holdings Group Inc. raised its position in Aveanna Healthcare by 24.9% in the fourth quarter. Westwood Holdings Group Inc. now owns 4,163,789 shares of the company’s stock worth $30,812,000 after acquiring an additional 829,270 shares in the last quarter. Finally, LGT Capital Partners LTD. raised its position in Aveanna Healthcare by 41.5% in the first quarter. LGT Capital Partners LTD. now owns 1,450,000 shares of the company’s stock worth $4,944,000 after acquiring an additional 425,000 shares in the last quarter. 95.00% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile (Get Rating)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.

Featured Articles

Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.